Le Lézard
Classified in: Health, Science and technology
Subject: Sales

MedinCell: Publication of the Activity Report and Financial Information for the First Half-year (April - Sept. 2019)


MedinCell (Paris:MEDCL):

Progression of the portfolio with FDA IND clearance to initiate clinical activities for mdc-TJK and mdc-ANG entering preclinical

Launch of Animal Health activities

Revenue increase and strong cash position in line with expectations

Post-closing events

The information contained in this press release will be commented by the MedinCell management team during an online conference on December 3, 2019. The comments and answers to participants' questions will be available on invest.medincell.com

Press release related to half-year events is available on MedinCell's website: https://invest.medincell.com/#news


These press releases may also interest you

at 10:05
Sibel Health awarded a major grant to advance maternal monitoring solution for low-and-middle income countries.
Grant support from the Bill & Melinda Gates Foundation will extend Sibel Health's AI-enabled, and FDA-cleared ANNE® One monitoring solution to improve maternal health monitoring globallySibel Health partners with the University of Edinburgh and the...

at 10:03
EMPOWERING WOMEN: pH-D FEMININE HEALTH'S COMMITMENT TO VAGINAL WELLNESS
According to recent findings in Statista, "the United States is experiencing a growing demand for eco-friendly and sustainable feminine hygiene products. [In fact], in the United States, the revenue generated in the Feminine Hygiene market is...

at 10:00
VPL Expands into Pharmaceutical Supply Chain with VPL Rx: Modernizing Logistics Ahead of 2024 Asembia Summit
VPL Rx, the clinically-minded prescription shipping, tracking, and compliance platform, announces its expansion into the pharmaceutical supply chain, setting a new standard for streamlined...

at 10:00
Binder Animal Hospital in St. Louis, Missouri Introduces Same-Day Urgent Care Services
Binder Animal Hospital is thrilled to announce the expansion of its service offerings with the introduction of same-day urgent care for pets, available from 8 am to 8 pm, Monday through Saturday, effective April 1st, 2024. This development aims to...

at 10:00
ONTARIO BRAIN INSTITUTE LAUNCHES CENTRE FOR ANALYTICS
The Ontario Brain Institute (OBI) has opened the doors to its new Centre for Analytics with the launch of two transformative, data-driven projects....

at 10:00
Pillar Biosciences oncoRevealtm CDx pan-cancer solid tumor IVD now FDA approved for general tumor profiling on the Illumina MiSeqtm Dx System
Pillar Biosciences, Inc., the leader in Decision Medicinetm, which develops and distributes next-generation sequencing (NGS) tests to localize testing and reduce time to treatment initiation and testing costs, today announced that the U.S. Food and...

More news about Health...


News published on and distributed by: